Creso Pharma Ltd
ASX:CPH
Creso Pharma Ltd
ASX:CPH
Price:
0.008
AUD
Market Closed
Market Cap:
AU$17.7m
Income Statement
Earnings Waterfall
Creso Pharma Ltd
Creso Pharma Ltd
Income Statement
Creso Pharma Ltd
Creso Pharma Ltd
Currency: AUD
| Dec-2020 | Dec-2021 | Dec-2022 | ||
|---|---|---|---|---|
| Revenue | ||||
| Revenue |
2
N/A
|
6
+154%
|
9
+41%
|
|
| Gross Profit | ||||
| Cost of Revenue |
(2)
|
0
|
(8)
|
|
| Gross Profit |
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | ||||
| Operating Expenses |
(16)
|
(33)
|
(20)
|
|
| Selling, General & Administrative |
(10)
|
(27)
|
(17)
|
|
| Research & Development |
(0)
|
0
|
0
|
|
| Depreciation & Amortization |
(0)
|
(0)
|
(3)
|
|
| Other Operating Expenses |
(5)
|
(6)
|
(1)
|
|
| Operating Income |
(15)
N/A
|
(27)
-73%
|
(20)
+27%
|
|
| Pre-Tax Income | ||||
| Interest Income Expense |
(5)
|
(1)
|
(0)
|
|
| Non-Reccuring Items |
(10)
|
(3)
|
(13)
|
|
| Gain/Loss on Disposition of Assets |
0
|
0
|
(0)
|
|
| Total Other Income |
0
|
0
|
0
|
|
| Pre-Tax Income |
(31)
N/A
|
(30)
+2%
|
(33)
-9%
|
|
| Net Income | ||||
| Tax Provision |
0
|
0
|
(0)
|
|
| Income from Continuing Operations |
(31)
|
(30)
|
(33)
|
|
| Income to Minority Interest |
0
|
0
|
0
|
|
| Net Income (Common) |
(31)
N/A
|
(30)
+2%
|
(33)
-9%
|
|
| EPS (Diluted) |
-0.08
N/A
|
-0.03
+63%
|
-0.02
+33%
|
|
Switch to:
Switch to:
See Also
Discover More
